Introduction to *S.* Typhimurium Pathogenesis and Virulence
===========================================================

Salmonellosis in humans and food animals caused by *S.* Typhimurium is characterized by fever, acute intestinal inflammation, and diarrhea within 24 h after infection. *Salmonella* employs multiple virulence factors to overcome colonization resistance and induce intestinal inflammation ([@B45]). After entering the intestinal lumen, *Salmonella* uses flagella to move to the proximity of the intestinal epithelial cells and uses fimbriae for intimate cell attachment (**Figure [1](#F1){ref-type="fig"}**). Fimbriae bind the extracellular matrix glycoprotein laminin and mediate adhesion to the host cell. The autotransporter protein, MisL ([@B75]; [@B42]), binds to fibronectin and *Salmonella* adhesins (SiiE and BapA) allow the bacteria to tightly adhere to the intestinal epithelium ([@B45]). *Salmonella* pathogenicity islands 1 (SPI-1) and 2 (SPI-2) encode two type III secretory systems (T3SS) that are syringe-like apparatuses *Salmonella* uses to translocate bacterial proteins into host cells. The SPI-1 T3SS (T3SS-1) is associated with invasion of epithelial cells. Structural proteins build the molecular syringe structure of the T3SS. *Salmonella* injects effector proteins SipA, SopA, SopB (SigD), SopD, and SopE2 via the needle into the host cell where they trigger cytoskeletal rearrangement and bacterial engulfment (reviewed in detail by [@B108]). The T3SS-1 effectors also induce fluid secretion and promote inflammation ([@B147]). Throughout the invasion process, signaling via pathogen-associated molecular patterns such as flagella and lipopolysaccharide (LPS) induces inflammation. Once inside *Salmonella*-containing vacuoles (SCVs), *Salmonella* induces expression of a second T3SS, encoded on SPI-2. In epithelial cells, *Salmonella* can persist within or escape from the SCV to replicate in the cytoplasm. In macrophages, which are naturally phagocytic, *Salmonella* interferes with the assembly of the NADPH oxidase complex in the phagosomal membrane, thereby preventing superoxide production and allowing the bacteria to survive inside the cell ([@B13]). Concomitant with invasion, epithelial cells, mononuclear cells and complement recognize *Salmonella* and other pathogens and trigger IL-1β, IL-12, IL-18, IL-23, TNF-α, INF-γ, and C5a production. These signals instruct the host to implement antibacterial responses including macrophage activation, recruitment of neutrophils, and release of antimicrobial peptides such as α-defensins and cathelicidins by epithelial cells. Activated macrophages and neutrophils release reactive oxygen radicals that are toxic to commensal microbiota but *S*. Typhimurium detoxifies ([@B9]; [@B33]; [@B120]; [@B162]). Therefore, in a hostile take-over, *S*. Typhimurium induces an inflammatory immune response which not only creates new resources like tetrathionate for *S.* Typhimurium, but also reduces resident microbiota thereby making already existing resources available for *S.* Typhimurium. Hence, the *Salmonella* induces an inflammatory immune response that allows it to compete with commensal microbiota and effectively colonize the gut ([@B62]; [@B45]).

![***Salmonella* Typhimurium pathogenesis and virulence.** In the intestinal lumen, *Salmonella* uses flagella to move close to the intestinal epithelial cells and uses fimbriae and adhesins (SiiE, BapA) for intimate cell attachment. Through, the type III secretion system encoded on pathogenicity island 1 (T3SS-1), *Salmonella* injects effector proteins SipA, SopA, SopB (SigD), SopD and SopE2 into host cells where they trigger cytoskeletal rearrangement, bacterial engulfment and formation of *Salmonella*-containing vacuole (SCV). The T3SS-1 effectors induce secretion of inflammatory cytokines and antimicrobial peptides by epithelial cells. A second type III secretion system encoded on *Salmonella* pathogenicity island 2 (T3SS-2) is expressed within the SCV. Proteins secreted through T3SS-2 prevent production of reactive oxygen species (ROS) and enables *Salmonella* to survive inside macrophages.](fmicb-07-01827-g001){#F1}

Multidirectional Signaling in the Gut and Effect on *S.* Typhimurium
====================================================================

Quorum sensing (QS) is a method of bacterial cell-to-cell signaling which allows the bacteria to coordinate gene expression at the population level. Receptors on bacterial cells recognize secreted molecules and initiate expression of downstream genes, including those involved in synthesis of QS compounds.

In the gastrointestinal environment bacteria produce hormones and hormone-like substances ([@B123]; [@B84]) or modify the host's signaling molecules, thus, affecting the host ([@B6]; [@B166]). Additionally, interspecies and interkingdom signaling modulate bacterial growth and virulence of pathogenic bacteria ([@B81]; [@B126]).

*Salmonella* Typhimurium Autoinducers and their Role in Virulence
-----------------------------------------------------------------

### Autoinducer-2

More than a decade ago [@B142], discovered that *Escherichia coli* and *S.* Typhimurium secrete a small, soluble, heat-labile, signaling molecule, which was named autoinducer-2 (AI-2). The signal concentration in growth media was maximal at the mid-exponential phase yet disappeared from the media at the beginning of the stationary phase in coordination with glucose depletion ([@B140]). Additionally, AI-2-dependent signaling required low pH and high osmolality, whereas low osmolality induced signal degradation ([@B141]).

Autoinducer-2 production in *S.* Typhimurium depends on a series of enzymatic reactions (**Figure [2](#F2){ref-type="fig"}**). First, methyl transferases convert *S*-adenosyl methionine (SAM) to *S*-adenosylhomocysteine (SAH), then methylthioadenosine/*S*-adenosylhomocysteine nucleosidase (Pfs) and *S*-ribosylhomocysteinase (LuxS) convert SAH to 4,5 dihydroxy-2,3-pentanedione (DPD). Finally, DPD is cyclized into (2R, 4S)-2-methyl-2,3,3,4-tetrahydroxytetra-hydrofuran (R-THMF, AI-2) ([@B143]; [@B97]). *Salmonella* Typhimurium produces and releases the majority of the AI-2 during exponential growth ([@B143]) and membrane transport protein YdgG may be involved in the extracellular transport of AI-2 ([@B65]). Extracellular AI-2 binds to autoinducer binding protein LsrB and is transported into bacterial cell via the ATP transporter encoded on *lsr* operon by *lsrACDB* ([@B164]). The phosphoenol pyruvate phosphotransferase system (PTS) is essential for initial ABC transporter activation and AI-2 internalization ([@B114]). A cytoplasmic kinase, LsrK, phosphorylates internalized AI-2 ([@B143]). Phosphorylated AI-2 inactivates the transcriptional repressor protein LsrR in a dose-dependent manner ([@B164]) and induces *lsrACDBFGE* operon transcription ([@B143]). The LsrR protein, encoded on the *lsr* operon, binds two loosely conserved sites on *lsr*, thus, repressing the transcription of *lsrACDBFGE* and itself ([@B164]). Phospho-AI-2 is degraded by LsrG and LsrF. Since the *lsr* expression is delayed but not completely halted in a *lsrB* mutant, there may be an alternative AI-2 transporter in *S*. Typhimurium ([@B143]). Transcriptome analysis suggests that *rbsB* gene encoding ABC superfamily [D]{.smallcaps}-ribose transport protein may be involved in the AI-2 transport in *S.* Typhimurium ([@B71]). In *S.* Typhimurium, LsrR, also negatively regulates expression of genes involved in the oxidative stress response (*sodA, sodCI, sodCII*), which, in turn lowers the bacterial ability to survive within macrophages ([@B27]). Additionally, LsrR represses flagella expression and invasion. Inactivation of LsrR by the presence of phosphorylated AI-2 allows SPI-1 (*invF, sicA, sopB, sopE*) and flagella (*fliC, fliD*) gene transcription ([@B28]).

![***Salmonella* Typhimurium autoinducer-2 (AI-2) signaling.** The signaling molecule AI-2 is produced by LuxS during an exponential growth, is exported by an unknown mechanism (possibly by YdgG), and accumulates extracellularly. Extracellular AI-2 is sensed by the *lsr*-encoded transport cassette and is actively transported into the bacterial cell. Following intracellular phosphorylation by LsrK, AI-2 negatively regulates the transcriptional repressor protein LsrR, allowing the transcription of *lsr*- and SPI-1 -- encoded genes as well as flagellar genes.](fmicb-07-01827-g002){#F2}

Although, the *lsr* operon is the only system known to be directly regulated by AI-2 in *E. coli* and *Salmonella*, proteomic analysis revealed that deletion of *luxS* in EHEC affected a variety of cell functions, including cell signaling, metabolism, information storage and processing, possibly through repressed tryptophan biosynthesis ([@B133]). More than 500 genes were differentially expressed between wild type (WT) *S.* Typhimurium and a *luxS* mutant *in vitro* ([@B71]). Deletion of *luxS* decreased the expression of genes encoding flagellar motility and chemotaxis as well as genes encoded on SPI-1 and *lsr*; however, the expression of *hilD*, *hilA*, *sipB*, and *invABCE* virulence factors increased ([@B71]). Phenotypically, deletion of *luxS* resulted in a decreased motility and virulence *in vitro*, which was restored by AI-2 supplementation in the media ([@B29]). A *S*. Typhimurium *luxS* mutant was also defective for epithelial cell invasion and virulence in mice ([@B29]). A combination of signals can modify AI-2 dependent virulence in *S.* Typhimurium. For example, *luxS* mutants have been shown to grow poorly in nutrient-poor M9 minimal medium. The addition of AI-2 restored growth of *luxS* mutants in minimal media but did not restore their ability to invade or survive in macrophages. Supplementation of the minimal media with both AI-2 and with long chain fatty acids (linoleic, oleic, palmitic, stearic) restored growth and macrophage invasion ([@B159]). This connection between AI-2 and nutrient utilization suggests that, in addition to QS molecules, nutrient availability under complex conditions such as those encountered in the gut may affect *S.* Typhimurium signaling and virulence.

Interestingly, *E. coli* is able to intercept extracellular AI-2 produced by other bacterial species *in vitro* ([@B113]). As the microbiota produces AI-2 like molecules ([@B98]), it is possible that *Enterobacteriaceae* can utilize interspecies signaling in the gut. In *E. coli*, chemotaxis to AI-2 depends on the [L]{.smallcaps}-serine receptor, Tsr, and the AI-2-binding protein, LsrB ([@B64]). In addition to regulation of virulence, increased concentrations of AI-2 promoted plasmid exchange between two different strains of *E. coli* ([@B26]) suggesting that AI-2-dependent QS may facilitate genetic information exchange, although this has not been directly shown in *S.* Typhimurium.

### AI-3/NE/Epi

[@B134] discovered autoinducer 3 (AI-3) production by *Enterobacteriaceae*; however, the synthetic pathway and chemical formula of AI-3 are still unknown ([@B158]). The two-component regulators associated with AI-3 are also associated with recognition of host catecholamines (CAs) epinephrine (Epi), and norepinephrine (NE). *Salmonella* and *E. coli* respond to host catecholamines through two-component regulatory systems. *Salmonella* Typhimurium encodes orthologs of the *E. coli* two-component regulatory systems QseC/B (PreB/PreA) and QseF/E ([@B93]; [@B116]), where QseC and QseE are histidine sensor kinases and QseB and QseF are, respectively, their associated response regulators. QseC is able to sense AI-3 as well as Epi and NE, while QseE can recognize Epi and NE along with sulfate and phosphate ([@B99]). The adrenergic histidine kinase, QseC, autophosphorylates upon binding to AI-3/Epi/NE and then dephosphorylates the response regulator QseB, inducing SPI-2 gene expression ([@B15]; [@B100]). The QseC/QseB two-component regulatory system controls virulence factors such as motility, invasion through SPI-1 genes and survival in macrophages through SPI-2, genes ([@B100]). QseE senses NE, Epi, phosphate, and sulfate and acts on the response regulator QseF, which induces the expression of SPI-1 genes (**Figure [3](#F3){ref-type="fig"}**). The Sperandio group proposed a QseC/QseE interplay model, where QseC phosphorylates QseF, thus indirectly controlling motility and invasion virulence factors encoded by SPI-1. Overall, it seems that QseE plays an important role during epithelial cell invasion, while QseC is more important in systemic disease and intramacrophage replication ([@B99]). The QseC-dependent signaling can be blocked by the α-adrenergic antagonist phentolamine ([@B31]); however, the effect of adrenergic antagonists on QseE is yet to be determined.

![**AI-3/NE/Epi quorum sensing in *S*. Typhimurium.** Intestinal catecholamines are sensed by *S.* Typhimurium QseC/B and QseE/F regulatory systems. The sensor kinase QseE detects Epi, which leads to phosphorylation of response regulator QseF and subsequent induction of cell invasion genes encoded on SPI-1. Sensor kinase QseC autophosphorylates upon sensing Epi, NE and AI-3, and activates genes encoded by SPI-2 required for intracellular survival) through dephosphorylated response regulator QseB. QseE and QseC indirectly regulate SPI-2 and SPI-1 through QseB and QseF respectively. QseC-dependent increase in horizontal gene transfer and motility can be blocked by adrenergic antagonists phentolamine and propranolol. NE metabolite DHMA is sensed by serine chemoreceptor Tsr and induces chemotaxis.](fmicb-07-01827-g003){#F3}

In *Salmonella*, catecholamines induce growth in iron-restricted media ([@B50]; [@B116]) and facilitate the expression of genes encoded on SPI-1 (*sipA, sipB*) and SPI-3 (*mgt*) thus modulating virulence of *S.* Typhimurium *in vitro* and *in vivo* ([@B100]). It is unclear whether NE-dependent enhancement of bacterial growth, motility and virulence depends on QseC/E signaling ([@B100]; [@B116]). It has been shown that the alpha-adrenergic antagonist, phentolamine, and the beta-adrenergic antagonist, labetalol, can neutralize norepinephrine-induced enhancement of motility ([@B15]; [@B165]) suggesting similarity between bacterial and mammalian targets for adrenergic receptors. It is important to note that the chemoattractant properties of NE are in fact attributed to a bacterial NE metabolite, 3,4-dihydrohymandelic acid (DHMA). When the bacterial cell senses NE via QseC, the cell induces transcription of tyramine oxidase (*tynA*) and aromatic aldehyde dehydrogenase (*feaB*), which are involved in 3,4-dihydroxyphenylglycolaldehyde (DOPEGAL) and DHMA production. The latter is sensed by the bacterial serine chemoreceptor Tsr, which induces concentration-dependent chemotaxis of *E. coli* ([@B112]). Catecholamines may also play a role in transfer of antimicrobial resistance between *Salmonella* and *E. coli*, as physiological concentrations of NE (5 μM) have been shown to enhance plasmid transfer between *S.* Typhimurium and commensal *E. coli* in iron-rich lysogeny broth (LB) broth. Phentolamine, an α-adrenergic antagonist, and propranolol, a beta-adrenergic antagonist, inhibited NE-induced plasmid transfer ([@B115]). Finally, catecholamine signaling may be involved in AI-2-dependent virulence regulation in *Enterobacteriaceae* as microarray analysis revealed that NE and Epi decrease the expression of *lsr* operon in *E. coli* O157:H7 *in vitro* ([@B11]).

Interspecies and Interkingdom Communication
-------------------------------------------

### Acyl-Homoserine Lactone

Several bacterial species such as *Vibrio cholera*, *Klebsiella pneumoniae*, and *Pseudomonas aeruginosa* utilize acyl-homoserine lactone (AHL) signaling ([@B49]). In gram negative bacteria AHL is synthesized by LuxI, which binds to its cognate receptor LuxR, which subsequently binds specific DNA promoters and activates transcription of target genes ([@B46]). Unexpectedly, in the mammalian gut, AHL was detected only in the bovine rumen where its concentration was correlated with the summer and spring seasons and colonization with *E. coli* O157:H7; however, it is not known which members of the rumen microbiota produce AHL ([@B43]; [@B67]).

In *S.* Typhimurium, AHLs stimulate biofilm formation by regulating glycogen biosynthesis (*glgC*), fimbriae (*fliF*, *lpfA*, and *fimF*) and SPI-1 genes (*hilA*, *invA*, and *invF*) ([@B24]). *Salmonella* spp. do not encode AHL synthase and do not produce AHL. Instead, *S.* Typhimurium utilizes the SdiA receptor, which is able to sense AHL produced by other bacterial species ([@B1]; [@B96]; [@B130]) when grown on motility agar or during the late exponential phase in liquid culture ([@B132]). Environmental conditions such as low pH, high iron concentrations, or growth in spent media, have been shown to repress *sdiA* expression in *S.* Typhimurium. In mice, infection with a *sdiA* mutant lacking AHL signaling resulted in increased fecal shedding and bacterial loads in the livers of infected mice ([@B157]) indicating that SdiA may be a negative regulator of virulence. Together, these data suggest that while no detectable concentrations of AHL have been found in the mammalian intestine to date, there may be individual bacteria that secrete small quantities of AHL. This idea is supported by the finding that the *Salmonella* AHL-receptor SdiA was activated in the GI tract of turtles colonized with *Aeromonas hydrophila* ([@B131]). Alternatively, *S.* Typhimurium may utilize the SdiA sensor kinase for other functions such as the detection of other QS molecules such as indole ([@B78], [@B79]), and to facilitate antimicrobial resistance ([@B105]; [@B153]).

### AI-2/AI-3

In the mammalian gut two dominating phyla, Bacteroidetes and Firmicutes, are predicted to produce the majority (17 and 83% respectively) of AI-2 ([@B149]). Within Firmicutes, 97% of Bacilli, 49% of Clostrida and 27% of other taxonomic classes are predicted to have AI-2 production capabilities ([@B149]). Streptomycin has been shown to dramatically shift microbiota composition in the murine gut in the favor of Bacteroidetes ([@B149]). However, concurrent introduction of the *E. coli lsrK* mutant, which overproduces AI-2, increased relative abundance of Firmicutes in streptomycin-treated mice and decreased the Bacteroidetes to Firmicutes ratio ([@B149]). Thus, AI-2 signaling diminishes the effect of streptomycin-induced dysbiosis on microbiota ([@B149]). The microbiota is not the only potential source of AI-2 in the gut. Intriguingly, mammalian cells of epithelial lineage, such as Caco-2 produce a compound which mimics bacterial AI-2 and is detectable by reporter *Vibrio* strain. Increased production of this AI-2 mimic is induced by bacteria, especially when the tight junctions between enterocytes are compromised. This suggests that secretion of signaling molecules, such as the AI-2 mimic by the host allow it to manipulate bacterial behavior in the gut possibly as a protective measure against bacterial transit from the intestinal lumen to the circulatory system ([@B69]).

AI-3 signaling has been described in several bacterial species such as *E. coli*, *Salmonella* sp*., Shigella* sp., *Klebsiella pneumoniae*, and *Enterobacter cloacae in vitro* ([@B134]; [@B158]) and the AI-3 dependent QseC/E system is activated by catecholamines, which are abundant in the mammalian gut ([@B99]). The importance of AI-3 communication in gastrointestinal dysbiosis has not been extensively investigated but might offer unique opportunities for management of gastrointestinal diseases or systemic and behavioral conditions associated with gastrointestinal dysbiosis.

### Gut Microbiota Is Involved in the Modulation of Catecholamines

The majority of CA \[NE, Epi, dopamine (DA)\] found in blood and urine is conjugated (glucuronide- or sulfate-conjugated) and biologically inactive ([@B167]; [@B58]). Free CA as well as sulfotransferase enzymes, which conjugate free CA, are gradually distributed in the gut with the lowest concentration in the stomach and highest concentration in the large intestine, which correlates with bacterial loads in these organs ([@B63]; [@B6]).

It has been recently discovered that the microbiota are involved in the production of biologically active free CAs in the murine intestine. The majority of the CA in the heavily populated cecum and colon of conventional mice were free (i.e., non-conjugated); while in the sparsely populated ileum a substantial amount of CA was conjugated ([@B6]). Moreover, the majority of CA in the lumen of germ free (GF) mice was conjugated, and their concentration was lower than in specific pathogen free (SPF) mice. Additionally, β-glucuronidase (GUS) activity, necessary for free CA production, was lower in GF mice. Fecal transplants from SPF mice increased the free CA concentrations and GUS activity in the intestinal lumen of GF mice ([@B6]). These data indicate the importance of commensal bacteria in GUS-dependent production of biologically active CA in the murine gut.

### Iron

Iron is essential for the bacterial cell; however, the majority of extracellular iron in the gut is bound by iron-chelating glycoproteins transferrin and lactoferrin. CA can bind to iron within transferrin and lactoferrin, resulting in release of iron from these complexes followed by their uptake by the bacterial siderophores -- enterobactin and salmochelin. Porin proteins OmpA and OmpC bring transferrin complexes close to the bacterial cell surface for more efficient uptake of CA-released iron by bacterial siderophores ([@B51]; [@B128], [@B127]). Porins also allow direct uptake of NE and DA which can enhance bacterial growth ([@B127]). For *Salmonella*, NE-induced growth requires the catecholate siderophore receptors IroN, FepA, and CirA ([@B161]) as well as siderophore hydrolysis, which liberates siderophore-bound iron in the cytoplasm ([@B161]; [@B16]; [@B95]). However, the catecholate transport systems may not be required for swine colonization by *S.* Typhimurium ([@B15]). The role of QseC/E signaling in NE-dependent bacterial growth needs to be further elucidated ([@B50]; [@B116]).

### Short Chain Fatty Acids

Microbiota, including pathogenic *E. coli* and *Salmonella* sp., produce short chain fatty acids (SCFAs; acetate, propionate, and butyrate) as the main end-fermentation products that are absorbed by colonic mucosa and used as an energy source by the host and bacteria ([@B35]). Recent work has demonstrated that microbiota differences between lean and obese children and adolescents correlate with altered proportions of SCFA in plasma and that SCFA are associated with body fat partitioning and *de novo* lipogenesis ([@B59]). In *S.* Typhimurium, SCFAs signal through a two-component regulatory system SirA/BarA primarily at the late exponential phase ([@B77]). BarA is a sensor kinase, which phosphorylates the response regulator SirA in response to extracellular signals. SirA then regulates virulence gene expression through the *csrBC*-CsrA regulatory cascade ([@B76]; [@B90]). A mixture of SCFAs similar to that found in the distal ileum was shown to induce the SPI-1 genes *hilA*, *invF*, and *sipC*, while a mixture of SCFAs mimicking the concentration and composition of colonic SCFAs had an opposite effect ([@B77]). Individually, propionate has been shown to decrease SPI-1 expression through the transcriptional regulator HilD ([@B68]). Furthermore, pre-incubation of *S.* Enteritidis with propionate and butyrate, but not formate, resulted in decreased epithelial cell invasion ([@B152]). Finally, in pigs, supplementation with a mixture of organic acids including propionate resulted in decreased *Salmonella* recovery from the mesenteric lymph nodes ([@B5]). Thus, dietary supplementation with SCFAs, particularly, propionate, may be a promising intervention strategy for decreasing *Salmonella* loads in farm animals.

### Indole Secreted by Commensal Bacteria Promotes Intestinal Health and Attenuates *S.* Typhimurium Virulence

To date, over 85 bacterial species have been found to produce the small signaling molecule indole. *E. coli* produces indole during the stationary phase with the help of tryptophanase (TnaA), which converts tryptophan into indole, pyruvate, and ammonia. Indole is generated exclusively by bacteria but can be absorbed by mammalian hosts; therefore, a number of indole derivatives found in blood are entirely dependent on supply of indole from intestinal microbiota ([@B160]). Indole has been shown to promote the health of the gastrointestinal barrier by increasing transepithelial resistance and decreasing inflammatory cytokine (IL-8, IL-10, and NF-κB) secretion and EHEC attachment ([@B10]). For *E. coli*, indole has been shown to induce SdiA-dependent and temperature-sensitive reduction in biofilm formation and motility ([@B80]).

Although *Salmonella* does not produce indole, it is able to sense indole produced by other bacterial species through an unknown mechanism. It has been suggested that indole signaling in *E. coli* occurs via the AHL receptor SdiA. Activation of SdiA by indole leads to reduced biofilm formation as well as reduced acid resistance ([@B78], [@B79]). However, another group determined that an indole associated decrease in biofilm formation in *S.* Typhimurium and *E. coli* was not dependent on SdiA. Instead, high indole concentrations were found to inhibit AHL detection by SdiA ([@B125]).

Recent studies have shown that *S.* Typhimurium uses the intercellular signaling molecule indole to increase antibiotic tolerance throughout its population by mediating oxidative stress and phage shock response ([@B153]) as well through induction of multidrug efflux pumps ([@B107], [@B106], [@B105]). Although indole is the primary metabolite produced from tryptophan by the microbiota, other microbiota-derived tryptophan metabolites exist and likely regulate other microbiota and pathogen properties ([@B11]; [@B78], [@B80]).

### Fucose

Fucose is an abundant sugar in the intestine and its production is microbiota-dependent. For instance, *Bacteroides thetaiotaomicron* facilitates fucose cleavage from glycans such as mucin ([@B163]). The two-component signal transduction system FusKR of enterohemorrhagic *E. coli* (EHEC) senses fucose and represses LEE expression in the mucus layer, thus preventing energy waste when bacteria are not in close proximity to epithelial cells ([@B111]).

In the intestinal lumen, *S.* Typhimurium expresses fucose utilization proteins FucI, FucU and FucA, which are seldom observed *in vitro* ([@B104]). It has been proposed that intestinal conditions, such as a shift in gut microbiome population, modulate substrate utilization by the pathogen. *Salmonella* Typhimurium exhibited increased expression of genes involved in metabolism of sialic acid, fucose and propanediol in *B. thetaiotaomicron*-monoassociated mice ([@B38]); however, the interplay between fucose sensing and virulence in *S.* Typhimurium is still unknown.

Gut--Brain Communication in Health and Disease
==============================================

The bidirectional gut--brain communication involves the central nervous system (CNS), neuroendocrine, neuroimmune, autonomous, and enteric nervous systems (ENS). Neurochemical signals travel from the gut via the afferent neurons while the efferent neurons carry signals from the brain to the gut, connecting the central and peripheral nervous systems. Physiological and psychological stressors induce the release of corticotropin-releasing hormone (CRH) from the hypothalamus which stimulates adrenocorticotropic (ACTH) release by the anterior pituitary gland. ACTH stimulates synthesis and secretion of cortisol by the adrenal cortex. It has been recently recognized that microbiota are involved in the development, function, and communication of the gut--brain, and, in particular, hypothalamic pituitary axis (HPA), which regulates the host response to stress ([@B37]; [@B82]; [@B52]). The catecholamine stress hormone NE is released in the gut via the sympathetic nervous system ([@B138]). At low and high concentrations NE binds to α and β adrenergic receptors of plasma membranes, respectively ([@B138]). NE has segment-specific activity in the intestine. Additionally, NE-mediated epithelial response in the proximal and distal colon can be suppressed by α-blocker phentolamine and β-blocker propranolol respectively ([@B66]). Thus, neuroendocrine-immune intercommunication of the gut--brain axis is important in both the healthy and disease state of animals and humans.

Gut--Brain Communication: Microbiota to Host
--------------------------------------------

### Neurochemicals and QS Molecules

The neurotransmitter serotonin \[5-hydroxytryptamine (5-HT)\], which regulates mood, appetite and sleep is a striking example of a neurochemical which production depends on gut microbiota. The majority (∼90%) of 5-HT is synthesized in the gut ([@B91]) and is microbiota-dependent, because plasma concentrations of serotonin were almost 3-fold higher in the conventional mice compared to GF animals ([@B160]). Hallmark studies determined that gut microbiota, particularly spore-forming bacteria, modulate intestinal metabolites alpha-tocopherol, butyrate, cholate, deoxycholate, *p*-aminobenzoate, propionate, and tyramine to act directly on enterochromaffin cells, stimulating synthesis of serotonin biosynthetic enzyme, Tph1, thus promoting serotonin synthesis ([@B119]; [@B166]). However, the systemic effect of bacterial regulation of serotonin biosynthesis on distal tissues and organs is unknown ([@B91]).

Tryptophan is another example of microbiota-dependent metabolism of signaling molecules. Serum tryptophan concentrations were significantly higher in GF mice since they were lacking microbes that convert tryptophan to indole. Additionally, an indole metabolite, indole-3-propionic acid (IPA), has been identified only in plasma of conventional mice and colonization of GF mice with the commensal bacterium, *C. sporogenes*, restored IPA in the serum of GF mice to the levels found in conventional mice ([@B160]).

Sex hormones have also been implicated in the modulation of the brain-gut axis at the CNS, autonomous NS and ENS levels with certain differences seen between males and females in pain perception and HPA response. Brain-microbiota communication may also be modulated by sex hormones ([@B101]), while bacteria can synthesize steroid metabolizing enzymes thus modulating the host ([@B18]). For example, microbial β-glucuronidase deconjugates estrogens in the gut and makes them available for reabsorption via enterohepatic circulation ([@B48]; [@B89]). Additionally, *S*. Typhimurium has been found to alter multiple host metabolic pathways, particularly those that regulate synthesis and degradation of steroid hormones ([@B3]). Finally, the microbiota is required for biologically active CA production (NE, Epi, and dopamine) in the intestinal lumen, which can be utilized by the host and microbiota ([@B6]). Conversely, estrogen receptor β (ERβ) status affects species richness and relative abundance of prominent phylotypes of murine fecal microbiota composition, where relative abundance of Bacteroidetes and Proteobacteria was higher in ERβ^+/+^ ERβ^-/-^ and mice ([@B92]).

### Microbiota Regulates the Hypothalamic Pituitary Axis

It is known that microbiota aids in the brain development and metabolism (reviewed in [@B60]). Additionally, gut microbiota plays an important role in regulation of the HPA, particularly, in modulating the host's response to stress ([@B41]). For example, the gut microbiota initiates signaling which affects neurons involved in motor control and anxiety-like behavior ([@B40]) independently of inflammation, GI, or vagal signaling ([@B17]). In another study, GF rats exhibited decreased social communication, increased anxiety-like behavior and neuroendocrine response to acute stress ([@B34]). Finally, GF mice had exaggerated responses to stress indicated by the elevated concentration of stress hormones ACTH and corticosterone relative to their non-GF genetically similar counterparts. GF mice also expressed decreased levels of brain-derived neurotrophic factor in the cortex and hippocampus, which was reversed by introducing *Bifidobacterium infantis* in the early postnatal stage ([@B139]). Together these studies demonstrate the importance of microbiota in the host response to stress mediated by the HPA axis.

There is further evidence that hyper-responsiveness of the HPA can be reversed by probiotic bacterial species. In mice, supplementation with *Lactobacillus rhamnosus* (*JB*-1) has been shown to regulate the expression of the main CNS inhibitory neurotransmitter γ-aminobutyric acid (GABA) ([@B19]). Furthermore, supplementation with *L. rhamnosus* decreased plasma concentrations of corticosterone and resulted in reduced anxiety and depression-like behavior in mice ([@B19]). Another probiotic, *Bifidobacterium longum* NCC3001, normalized anxiety-like behavior when given to mice with chronic colitis ([@B17]). Additionally, administration of a probiotic formulation consisting of *Lactobacillus helveticus* R0052 and *B. longum* R0175 for 30 days decreased anxiety-like behavior in rats and alleviated physiological distress and urinary cortisol in healthy humans ([@B94]).

It has been determined that exposure to stressors, including social stress and response to environmental stressors, changes composition and density of the gut microbial community ([@B7]). For instance, social stress decreased the genus *Bacteroides* and increased the abundance of the genus *Clostridium* in mice. Stress induced an increase of serum concentrations of cytokines IL-6 and MCP-1, which were inversely correlated with the relative abundance of *Coprococcus*, *Dorea*, and *Pseudobutyrivibrio* species ([@B8]). Interestingly, mice pre-treated with antimicrobials to reduce microbiota did not develop increases in IL-6 and MCP-1, suggesting that the observed increase in cytokines in stressed mice was induced by microbiota ([@B8]). Research has shown that stress in early life, such as maternal separation, alters behavior, immunity and microbiota in rats. Stressed pups exhibited increased systemic concentrations of plasma corticosterone as well as TNF-α and INF-γ along with increased visceral sensation ([@B56]; [@B110]). Administration of probiotics ameliorated the signs of gut dysfunction and decreased corticosterone concentrations in these rat pups ([@B56]). The probiotic *Lactobacillus farciminis* was found to be effective in alleviating intestinal permeability as well as corticosterone, ACTH and pro-inflammatory cytokine concentrations induced by LPS treatment in female rats ([@B2]).

Temperament in animals is associated with responsiveness of the HPA and resting levels of cortisol ([@B36]; [@B129]) and differential immune response to bacterial infection ([@B22]). In mice, gut microbiota may regulate the HPA and stress responsiveness, possibly by directly regulating neuronal expansion and morphology. For example, microbiota-deficient mice exhibited expansion of amygdala and hippocampus ([@B83]). Interestingly, in young children an association has been discovered between temperament and the microbiota ([@B30]). Particularly, increased surgency/extraversion, sociability and high-intensity pleasure was associated with increased alpha diversity in both sexes ([@B30]). In finishing cattle calm temperament was associated with increased *E. coli* O157:H7 shedding following transportation stress ([@B129]).

Stress and Microbiota: Role in *S.* Typhimurium Pathogenesis
------------------------------------------------------------

*Salmonella* Typhimurium induces enteritis characterized by neutrophil infiltration, submucosal edema, goblet cell depletion, epithelial disruption, and crypt abscesses ([@B45]). In the gut, *Salmonella* employs strategies that allow it to compete with resident microbiota and eventually overcome colonization resistance. Ultimately, *Salmonella*-induced disruption of the microbiota may disrupt regulation of the nervous system by microbiota-derived metabolites.

### Dysbiosis Benefits *S.* Typhimurium

Disturbance in microbiota density and composition have long been associated with increased susceptibility to salmonellosis. Mice infected with *S.* Typhimurium suffer systemic infection but about 95% do not develop gastrointestinal illness characteristic of *S.* Typhimurium infection in humans. Treatment of mice with a single dose of streptomycin 24 h prior to intragastric inoculation with *S.* Typhimurium leads to dramatically reduced microbiota density and diversity ([@B14]). Consequently, transient disruption of colonization resistance allows *S.* Typhimurium to establish itself in the cecum and colon as fast as 8--12 h post-infection, and to induce acute mucosal inflammation in mice. These observations have led to use of the streptomycin-treated mouse as a model of *Salmonella-*induced diarrhea in humans ([@B32]; [@B73]). There is a strong correlation between an antibiotic-induced (streptomycin, vancomycin, and metronidazole) microbiota shift and subsequent severity of *S.* Typhimurium-induced infection ([@B47]). Antibiotic treatment leads to a steep decrease in total bacterial microbiota numbers and is associated with increased systemic translocation of *S.* Typhimurium and prolonged intestinal inflammation relative to untreated mice infected with *S.* Typhimurium ([@B32]).

Intestinal inflammation helps WT and avirulent *Salmonella* to compete with microbiota and enhances *Salmonella* colonization in mice (**Figure [4](#F4){ref-type="fig"}**). However, the avirulent strain, which lacked two virulence-associated type III secretion systems, but not WT *Salmonella* was outcompeted by microbiota in the streptomycin mouse model ([@B137]). Additionally, WT was able to alter the microbiota composition (*Salmonella* was the predominant species, ∼90%) in streptomycin-treated mice compared to an avirulent strain ([@B137]).

![***Salmonella* outcompetes resident microbiota in the gut.** Host and resident microbiota protects against *Salmonella* colonization: indole secreted by commensals promotes intestinal health by decreasing secretion of proinflammatory cytokines and by decreasing *Salmonella* virulence gene expression and certain bacteria (*B. thermophilum* and Bacteroidetes) are associated with increased resistance to *Salmonella. Salmonella* uses microbiota-produced hydrogen for initial establishment in the intestine. *Salmonella* induces secretion of ROS and antimicrobial peptides by neutrophils and epithelial cells. While *Salmonella* is resistant to ROS, they are harmful to commensal microbes. In the inflamed intestine, microbiota-produced hydrogen sulfate is converted by the host to tetrathionate, which is used by *Salmonella* as an electron acceptor for anaerobic respiration and allows *Salmonella* to utilize ethanolamine, produced by the host as carbon source. Additionally, *Salmonella* -- produced bacteriocin, colicin, inhibits resident *Escherichia coli* in the intestine. Thus *Salmonella*-induced inflammation leads to dysbiosis and allows *Salmonella* to propagate in the gut. Some resident bacterial species contribute to *Salmonella* infection. For example, *A. muciphila* inhibits mucin production and aids *Salmonella* in decreasing goblet cell population. Additionally, fucose, which is cleaved from mucin by *B. thetaiotaomicron* is utilized by *Salmonella* at the initial colonization stage.](fmicb-07-01827-g004){#F4}

### *Salmonella* Typhimurium Induces Dysbiosis

*Salmonella* Typhimurium is able to modify gut microbiota even without antimicrobial pre-treatment. For example, oral *S.* Typhimurium infection induces SPI-1-dependent dysbiosis which is reversed within a month after inoculation ([@B12]). Interestingly, a change in microbiota composition preceded *S.* Typhimurium-induced diarrhea, suggesting a host-pathogen interaction resulting in dysbiosis but unrelated to diarrhea ([@B12]). One of the drivers of *Salmonella*-induced dysbiosis is the depletion of Clostridia, which are the main butyrate producers. Decrease of cecal butyrate leads to elevated oxygenation of colonocytes and increased aerobic proliferation of Bacilli, Bacteroidia, and Gammaproteobacteria (including *S.* Typhimurium) ([@B121]). Additionally, mice with low complexity microbiota (8--40 bacterial strains) were susceptible to *S.* Typhimurium-induced colitis even in the absence of pretreatment with streptomycin. Clearance of *Salmonella* can be facilitated by transferring microbiota from conventional mice to mice with the low complexity microbiota ([@B44]; [@B135]). Interestingly, mice colonized with commensal *E. coli* were more susceptible to *Salmonella*-induced inflammation, suggesting that closely related phylotypes displayed correlated abundances and pathogen blooms ([@B135]). These differences are not limited to mammalian hosts. In newly hatched chicks, *S.* Typhimurium does not cause clinical disease; however, it induces minor changes in the cecal microbiota ([@B72]). In adult chickens, *S.* Typhimurium infection led to an increase in *Enterobacteriaceae* and decrease in *Ruminococcaceae* in the cecum ([@B156]) although, overall changes in microbiota composition were much less pronounced compared to mammals.

Microbial metabolites can be beneficial for the initial pathogen assimilation in the gut. It has been shown that murine cecal microbiota produce approximately 2 μM hydrogen ([@B86]). Moreover, the genes encoding enzymes involved in the hydrogen production are abundant within the gut microbiota. In *S.* Typhimurium, hydrogen-consuming hydrogenases (*hyd*) are required for initial establishment in the intestine ([@B87], [@B86], [@B85]) and overcoming colonization resistance in SPF mice, whereas in the GF mouse the ability to consume hydrogen is not required ([@B86]). Interestingly, the inability of a *hyd3* mutant to consume microbiota-derived hydrogen did not affect *S.* Typhimurium colonization of systemic sites in the mouse ([@B85]). Therefore, hydrogen utilization is considered to be a general feature of *S.* Typhimurium necessary for gut colonization.

### *Salmonella* Typhimurium Exploits Intestinal Inflammation to Compete with Microbiota

Intestinal inflammation provides metabolic advantages to *Salmonella* to compete with resident microorganisms. Under normal conditions, the mammalian gut converts harmful hydrogen sulfide to thiosulfate ([@B53]). During inflammation induced by *S.* Typhimurium virulence factors SPI-1 and SPI-2, thiosulfate is oxidized to tetrathionate by reactive oxygen species (ROS). Subsequently, *S.* Typhimurium utilizes tetrathionate as an electron acceptor for anaerobic respiration, which allows the pathogen to outcompete the microbiota in the inflamed gut ([@B162]). Tetrathionate also acts as an electron acceptor allowing *S.* Typhimurium to utilize ethanolamine released from the host tissue. The *ttrA* gene encoding tetrathionate reductase subunit A is essential for *S.* Typhimurium growth in ethanolamine *in vivo* while the majority of gut microbiota are unable to use ethanolamine for fermentation ([@B148]).

*Salmonella* Typhimurium employs efficient mechanisms to compete for nutritional iron in the inflamed intestine. One of the mechanisms the pathogen uses is an induction of lipocalin-2 production by neutrophils. Lipocalin-2 is an antimicrobial protein which prevents iron acquisition in the intestine by commensal bacteria by binding to the siderophore, enterobactin. *Salmonella* Typhimurium produces a glycosylated variant of enterobactin, salmochelin, which utilizes transporter IroN. Salmochelin is not bound by lipocalin-2 and, therefore, gives *Salmonella* an advantage over IroN-negative bacteria ([@B118]). The lipocalin-2 resistance system has also been found in non-pathogenic Nissle strain of *E. coli* which is able to outcompete *S.* Typhimurium in a mixed infection and reduce pathogen numbers, making it a promising probiotic for preventative and therapeutic use ([@B39]). *Salmonella* Typhimurium also utilizes ferrous iron as co-repressor of siderophore synthesis in order to avoid damage by ROS secreted by immune cells. Production of iron-depleting agents such as lipocalin-2, lactoferrin, ROS and RNS by macrophages triggers ferric uptake regulator (*fur*)-dependent responses which control defense against peroxide. In addition to defensive mechanisms *S.* Typhimurium employs offensive tactics to compete in the gut such as production of antimicrobial bacteriocins. Intestinal inflammation triggers pore-forming, *fur*-dependent bacteriocin, colicin lb, which gives *Salmonella* an advantage over colicin-sensitive *E. coli* strains and allows *Salmonella* to "bloom" in the inflamed gut ([@B102]). In addition to inducing intestinal blooms of the pathogen, intestinal inflammation combined with microbiota disturbance has been shown to increase genetic material exchange between *Salmonella* and *E. coli* which could be prevented by commensal microbiota ([@B136]). Disruption of the microbiota leads to disruption of the communication between the microbiota and brain through altered chemical signaling between microbiota, gut, and brain (**Figure [5](#F5){ref-type="fig"}**).

![***Salmonella* induces dysbiosis and interferes with gut--brain communication.** Neural signals travel via efferent neurons from CNS to the ENS and back via afferent neurons. Microbiota stimulate synthesis and modulates bioavailability of neurochemicals such as 5-HT, NE, DA, and Epi which are utilized by the host. Stress stimulates the activation of HPA axis and release of cortisol and catecholamines. NE is released in the gut via spillover from sympathetic neurons. Resident microbiota use an array of quorum sensing signals which can be intercept by *Salmonella*. Catecholamines along with AI-2 and AI-3 QS molecules stimulate *Salmonella* growth and virulence in the intestine. Stress aids to *Salmonella* pathogenesis and induces dysbiosis, which helps *Salmonella* establishment in the intestine and dissemination via phagocytic cells.](fmicb-07-01827-g005){#F5}

### Microbiota Regulates Susceptibility to Infection

Some commensal bacteria develop synergistic relationships with *S.* Typhimurium. One such example is *Akkermansia muciphila* which causes increased pathology during *S.* Typhimurium infection by disturbing mucus production and sulfation. A combination of *A. muciphila* and *S.* Typhimurium significantly reduced numbers of mucin-filled goblet cells in the murine intestine, compared to uninfected mice or mice inoculated with either *A. muciphila* or *S.* Typhimurium alone. Presence of both bacteria increased *S.* Typhimurium proportions to 94% from 2.2% in an *S.* Typhimurium mono-infection. Additionally, expression levels of inflammatory cytokines INF-γ, IP-10, TNF-α, IL-12, IL-6, and IL-17 were significantly increased in mice infected with both bacteria compared to a single infection or uninfected mice. Thus, during *S.* Typhimurium infection commensal *A. muciphila* turns into a pathobiont and contributes to disease symptoms ([@B55]).

The gut microbiota induces systemic IgG production in response to GI infection, protecting the host from *Salmonella*-induced bacteremia. IgG production is accomplished in large part through TLR4 signaling in response to gram-negative murein lipoprotein ([@B168]). Particular members of the resident microbial community have been associated with increased resistance to infection. A study performed in conventional streptomycin-treated mice has shown that the Bacteroidetes phylum was associated with increased resistance to *S.* Typhimurium-induced colitis while *Lactobacillus* sp. was associated with decreased resistance ([@B47]). Also, a combination of commensal microbiota, particularly *Clostridium citroniae*, and gut metabolites exhibited antibacterial activity toward *S.* Typhimurium as well as reduced cell invasion ([@B4]). Finally, supplementation with the probiotic *Bifidobacterium thermophilum* RBL67 in combination with prebiotics \[fructo- (FOS), galacto- (GOS), and mannan- (MOS) oligosaccharides\] decreased *S.* Typhimurium colonization in a swine proximal colon simulation model ([@B145]). Co-culture of *B. thermophilum* RBL67 and *S.* Typhimurium at mid-exponential growth phase resulted in repression of regulatory gene *phoP* and flagella, although expression of SPI-1 genes, SPI-2 genes, and fimbriae was increased. The premature induction of virulence gene expression and reduced motility in *S*. Typhimurium induced by *B. thermophilum* RBL67 resulted in restricted colonization by the pathogen ([@B144]).

Stress Can Modify the Interaction between Host, Microbiota and *Salmonella*
---------------------------------------------------------------------------

Exposure to stress hormones has been shown to increase survival and virulence of *Salmonella* (by the mechanisms described above). For example, exposure of *S.* Typhi to NE and Epi induced release of toxin hemolysin E, which was attenuated by the β blocker propranolol ([@B74]). In another study treatment of intestinal tissues with 10 μM NE improved the uptake of *S.* Choleraesuis into porcine jejunal Peyer's patches ([@B61]). Likewise, incubation of *S.* Typhimurium in serum-SAPI medium with 2 mM NE prior to inoculation increased bacterial survival in the swine stomach and bacterial loads in the small intestine, large intestine and feces compared to bacteria grown in LB without NE ([@B151]). It was determined that density of the bacterial inoculum should be low for efficient NE-induced bacterial growth ([@B109]). Additionally, CAs can alter cellular uptake of *Salmonella* at early stages of infection. For example, increased dopamine concentrations at the contra-luminal aspect of the intestine resulted in decreased bacterial recovery from Payer's patches *ex vivo* ([@B20]) whereas cortisol increased intracellular *S.* Typhimurium proliferation in primary porcine alveolar macrophage cultures and in mice ([@B154]). The above mentioned effect is attributed to the cortisol-induced activation of regulator protein ScsA in *S.* Typhimurium which leads to increased SCV-production by macrophages allowing increased bacterial proliferation ([@B155]).

Not only does stress in the host aid the virulence of the pathogen, but it also increases host susceptibility to *S.* Typhimurium infection. To illustrate, feed withdrawal and heat stress in chickens were associated with increased *S.* Typhimurium numbers and increased intestinal pathology ([@B23]). Treatment of pigs with NE or the NE precursor, 6-hydroxydopamine (6-OHDA), which mimics acute stress, increased *Salmonella* shedding in pigs ([@B117]). Additionally, decreased fecal shedding exhibited by the *qseC* mutant was reversed by treatment of pigs with 6-OHDA prior to infection ([@B117]) which suggests that activation of QseC-dependent signaling by NE may not be required for *S.* Typhimurium virulence *in vivo*, as long there is an increase in stress hormone levels in the host. Another study demonstrated that, 24 h feed withdrawal or dexamethasone injections increased serum cortisol concentrations and *Salmonella* shedding in pigs ([@B154]).

Finally, a combination of stress and bacterial infection can affect resident microbiota in the GI tract ([@B146]) as well as gut--brain communication. For example, acute stress combined with *C. rodentium* infection induced memory dysfunction in mice, while infection alone did not result in memory impairment. Pigs infected with *Salmonella* exhibited subtle behavioral change as compared to uninfected control pigs despite having no obvious clinical signs of infection ([@B124]). Daily treatment with probiotics (*L. rhamnosus* R0011 and *L. helveticus* R0052) restored microbiota and prevented memory dysfunction in infected stressed mice. Probiotics also decreased serum corticosterone in mice and pro-inflammatory cytokine concentrations in these animals indicating that beneficial bacteria may ameliorate gastrointestinal illness and prevent memory alteration ([@B57]). It is unclear whether the exposure to stress during infection with gastrointestinal pathogens such as *S*. Typhimurium will affect memory or other brain functions in animals and additional study is warranted.

Concluding Remarks and Future Perspectives
==========================================

The evidence supports the hypothesis that microbiota communicates with the CNS and ENS through neural, endocrine, immune and humoral links ([@B25]; [@B21]) resulting in the microbiota having numerous effects on the health of the host ([@B122]). The gut microbiota helps shape and is shaped by the innate and adaptive immune systems and plays a role in host nutrition and neuroendocrine pathways ([@B54]; [@B88]; [@B150]). Further, mounting evidence suggests that the gastrointestinal microbiota is involved in the development and function of the mammalian nervous system ([@B103]; [@B70]).

The enteric pathogen *S*. Typhimurium employs a multitude of tactics to overcome colonization resistance by microbiota including (1) inducing inflammation which modulates nutrient availability by suppressing other bacteria; (2) through complex gene regulation pathways that link quorum signaling and metabolism; and (3) intercepting signals produced by the microbiota and host.

There is relatively little information on the effects of neuroendocrine hormones on *Salmonella* gene expression and virulence in animals despite decades of work suggesting that stress is associated with *Salmonella* shedding from people and animals. Future research should further investigate the multidirectional signaling in the GI tract to aid in our understanding of the communication between the host, resident microbiota and GI pathogens within the challenging environment of gastrointestinal tract.
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